4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Identification of scaffold proteins for improved endogenous engineering of extracellular vesicles

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Extracellular vesicles (EVs) are gaining ground as next-generation drug delivery modalities. Genetic fusion of the protein of interest to a scaffold protein with high EV-sorting ability represents a robust cargo loading strategy. To address the paucity of such scaffold proteins, we leverage a simple and reliable assay that can distinguish intravesicular cargo proteins from surface- as well as non-vesicular proteins and compare the EV-sorting potential of 244 candidate proteins. We identify 24 proteins with conserved EV-sorting abilities across five types of producer cells. TSPAN2 and TSPAN3 emerge as lead candidates and outperform the well-studied CD63 scaffold. Importantly, these engineered EVs show promise as delivery vehicles in cell cultures and mice as demonstrated by efficient transfer of luminal cargo proteins as well as surface display of different functional entities. The discovery of these scaffolds provides a platform for EV-based engineering.

          Abstract

          Extracellular vesicles are naturally occurring nanoparticles that are gaining ground as delivery modalities for therapeutics. Here, the authors conducted a large-scale screening programme to identify potential scaffold proteins for cargo loading into extracellular vesicles.

          Related collections

          Most cited references56

          • Record: found
          • Abstract: found
          • Article: not found

          The biology, function, and biomedical applications of exosomes

          The study of extracellular vesicles (EVs) has the potential to identify unknown cellular and molecular mechanisms in intercellular communication and in organ homeostasis and disease. Exosomes, with an average diameter of ~100 nanometers, are a subset of EVs. The biogenesis of exosomes involves their origin in endosomes, and subsequent interactions with other intracellular vesicles and organelles generate the final content of the exosomes. Their diverse constituents include nucleic acids, proteins, lipids, amino acids, and metabolites, which can reflect their cell of origin. In various diseases, exosomes offer a window into altered cellular or tissue states, and their detection in biological fluids potentially offers a multicomponent diagnostic readout. The efficient exchange of cellular components through exosomes can inform their applied use in designing exosome-based therapeutics.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Shedding light on the cell biology of extracellular vesicles

            Extracellular vesicles are a heterogeneous group of cell-derived membranous structures comprising exosomes and microvesicles, which originate from the endosomal system or which are shed from the plasma membrane, respectively. They are present in biological fluids and are involved in multiple physiological and pathological processes. Extracellular vesicles are now considered as an additional mechanism for intercellular communication, allowing cells to exchange proteins, lipids and genetic material. Knowledge of the cellular processes that govern extracellular vesicle biology is essential to shed light on the physiological and pathological functions of these vesicles as well as on clinical applications involving their use and/or analysis. However, in this expanding field, much remains unknown regarding the origin, biogenesis, secretion, targeting and fate of these vesicles.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Ceramide triggers budding of exosome vesicles into multivesicular endosomes.

              Intraluminal vesicles of multivesicular endosomes are either sorted for cargo degradation into lysosomes or secreted as exosomes into the extracellular milieu. The mechanisms underlying the sorting of membrane into the different populations of intraluminal vesicles are unknown. Here, we find that cargo is segregated into distinct subdomains on the endosomal membrane and that the transfer of exosome-associated domains into the lumen of the endosome did not depend on the function of the ESCRT (endosomal sorting complex required for transport) machinery, but required the sphingolipid ceramide. Purified exosomes were enriched in ceramide, and the release of exosomes was reduced after the inhibition of neutral sphingomyelinases. These results establish a pathway in intraendosomal membrane transport and exosome formation.
                Bookmark

                Author and article information

                Contributors
                samir.el-andaloussi@ki.se
                Journal
                Nat Commun
                Nat Commun
                Nature Communications
                Nature Publishing Group UK (London )
                2041-1723
                7 August 2023
                7 August 2023
                2023
                : 14
                : 4734
                Affiliations
                [1 ]GRID grid.4714.6, ISNI 0000 0004 1937 0626, Division of Biomolecular and Cellular Medicine, Department of Laboratory Medicine, , Karolinska Institutet, ; Huddinge, Sweden
                [2 ]GRID grid.10939.32, ISNI 0000 0001 0943 7661, Institute of Technology, , University of Tartu, ; Tartu, Estonia
                [3 ]GRID grid.410638.8, ISNI 0000 0000 8910 6733, Department of Hepatobiliary Surgery, , Shandong Provincial Hospital Affiliated to Shandong First Medical University, ; Jinan, China
                [4 ]GRID grid.410718.b, ISNI 0000 0001 0262 7331, Institute for Transfusion Medicine, , University Hospital Essen, University of Duisburg-Essen, ; Essen, Germany
                [5 ]GRID grid.24381.3c, ISNI 0000 0000 9241 5705, Clinical Research Center, , Karolinska University Hospital, ; Stockholm, Sweden
                Author information
                http://orcid.org/0000-0003-2416-5822
                http://orcid.org/0000-0002-4839-3822
                http://orcid.org/0000-0002-3804-0521
                http://orcid.org/0000-0001-9198-0857
                http://orcid.org/0000-0003-1176-8114
                http://orcid.org/0000-0003-0163-2678
                http://orcid.org/0000-0002-3653-7710
                http://orcid.org/0000-0003-4468-9113
                Article
                40453
                10.1038/s41467-023-40453-0
                10406850
                37550290
                0553ed79-e857-4775-9165-1930ae0f70b3
                © Springer Nature Limited 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 19 October 2022
                : 27 July 2023
                Categories
                Article
                Custom metadata
                © Springer Nature Limited 2023

                Uncategorized
                nanoparticles,protein delivery,therapeutics,assay systems,drug delivery
                Uncategorized
                nanoparticles, protein delivery, therapeutics, assay systems, drug delivery

                Comments

                Comment on this article